Navigation Links
FDA Approves Nasacort AQ(R) Nasal Spray for Children Aged 2-5 years old
Date:9/23/2008

Randomized, double-blind, placebo-controlled study conducted in the U.S. demonstrated both the efficacy and safety of Nasacort AQ(R) in children

with nasal symptoms associated with perennial allergic rhinitis

BRIDGEWATER, N.J., Sept. 23 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today the U.S. Food and Drug Administration (FDA) has approved Nasacort AQ Nasal Spray (triamcinolone acetonide) for children aged 2-5 years old for the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis.

The FDA based its approval on the results of a multicenter, randomized, double-blind, placebo-controlled study demonstrating that Nasacort AQ can be used safely and effectively to treat nasal symptoms of year-round allergies in children between two and five years. This is the first and largest placebo- controlled trial designed to specifically investigate both the efficacy and safety of an intranasal corticosteroid vs. placebo in 2-5 years of age group.

"We welcome this new treatment option for our very young patients," said lead investigator Dr. Steven Weinstein, Director, Allergy and Asthma Specialist Medical Group in Huntington Beach, California. "Nasacort AQ Nasal Spray has been proven effective for the age groups two to five years to relieve nasal allergy symptoms."

Approval Based on Pediatric Clinical Trial

The study showed that Nasacort AQ, given as 1 spray/nostril once daily for four weeks to children aged 2-5 years, with year-round allergic rhinitis diagnosed for at least one year, significantly improved the combined symptoms of sneezing, itching, runny nose and congestion, compared with placebo.

A total of 464 patients were randomized and received either Nasacort AQ or placebo as 1 spray per nostril once daily for 4 weeks. To participate in the study, patients had to have year-round allergic rhinitis diagnosed for at least one year and reported sufficiently severe symptoms of nasal s
'/>"/>

SOURCE sanofi-aventis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. ClearWay Minnesota(SM) Board Approves New Officers
2. FDA approves first drug for Huntingtons disease
3. The California Board of Registered Nursing Approves Affiliations for Nursing Program in Glendale, California
4. Kaiser Permanente Approves $22 Million in Community Benefit Grants in Second Quarter of 2008
5. Hillenbrand, Inc. Board of Directors Approves $100M Share Repurchase Program
6. Edwards Lifesciences Board Approves New $250 Million Share Repurchase Program
7. Congress Approves ePrescribing Initiative in Medicare Reform Bill: Critical Catalyst in Driving a New Generation of Prescribing
8. FDA Approves Genetic Test for Breast Cancer
9. FDA Approves KINRIX(TM) - New Combination Vaccine for Children
10. FDA Approves VELCADE(R) (Bortezomib) for Injection for Patients with Previously Untreated Multiple Myeloma
11. Japan Approves CyberKnife System for Extracranial Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... , ... July 31, 2015 , ... Ticket Down is ... Those looking to catch a new and refreshing show on Broadway, look no ... and achievements including an Obie Award, Outer Critics Circle Award, Drama Desk Award, Lucille ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... and potential patients alike on various plastic surgery procedures including, but not limited ... such popular dermatology procedures like Botox and fillers. , Staying up to ...
(Date:7/31/2015)... ... July 31, 2015 , ... “Engage: ... of the industry’s premier thought leadership symposiums, hosted by Massachusetts-based Harmony Healthcare ... The event attracts over 250 “C”-level executives, administrators, directors of nursing, rehabilitation managers ...
(Date:7/31/2015)... ... July 31, 2015 , ... BioViva USA, Inc. (“BioViva”), ... we treat aging diseases. , BioViva announces it has begun a fundraiser through ... Alzheimer’s Disease (AD) and find a cure. MaxLife will grant 100% of the money ...
(Date:7/31/2015)... ... 31, 2015 , ... The alarm was ringing. Hugh Chatfield, survivor of a severe 1987 brain ... recalled that his equipment was set up to depict the newly poured concrete. With a ... , The photo speaks for itself. Chatfield is also a highly praised safety and drug ...
Breaking Medicine News(10 mins):Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 2Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 3Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 4Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 5Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 6Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 7Health News:Cosmetic Town: Now Providing Interactive And Vital Medical Knowledge 2Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 2Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 3Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 2Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 3
... Longstanding CDH Relationship Remains Collaborative , ... , , ... ... WHEATON, Ill. , March 17 Life Care Services LLC (LCS) of ...
... financial rating tools are reliable , WEDNESDAY, March 17 ... reduce U.S. health-care costs, a new study suggests. , ... to encourage patients to receive care from doctors who ... these efforts may not be based on reliable estimates ...
... ... clinical trials , ... (Vocus) March 17, 2010 -- Guy Lee, M.D. , spine surgeon at Abington Memorial ... spinal stenosis using the Superion™ Interspinous Spacer (ISS) from VertiFlex® Inc., , ,The ...
... ... , ... ... BOISE, Idaho , March 17 Idahoans may soon learn someone else,s "conscience" at the worst possible time. ...
... deadly infections long has focused on looking for ways to ... of Utah and Utah State University shows that modulating the ... more lives. In a study published March 17 ... of U cardiologist Dean Y. Li, M.D., Ph.D., professor of ...
... The Community Oncology Alliance (COA) today announced the ... Selma, Alabama . That brings a total of at least ... --with the majority increasing from 2009 forward -- due to ... care. Yet the current healthcare reform plans do not address ...
Cached Medicine News:Health News:Wyndemere Senior Living Community Acquired by Life Care Services 2Health News:Wyndemere Senior Living Community Acquired by Life Care Services 3Health News:Wyndemere Senior Living Community Acquired by Life Care Services 4Health News:Ranking Doctors by Cost-Profile May Not Help Save Money 2Health News:Abington Surgeon First in Pennsylvania to Implant Investigative Device to Treat Leg Pain Caused by Spinal Stenosis 2Health News:Abington Surgeon First in Pennsylvania to Implant Investigative Device to Treat Leg Pain Caused by Spinal Stenosis 3Health News:Abington Surgeon First in Pennsylvania to Implant Investigative Device to Treat Leg Pain Caused by Spinal Stenosis 4Health News:Idaho Passes Bill to Put 'Conscience' Between Patients & End of Life Rights 2Health News:Idaho Passes Bill to Put 'Conscience' Between Patients & End of Life Rights 3Health News:Targeting blood vessels, immune system may offer way to stop infection-caused inflammation 2Health News:Targeting blood vessels, immune system may offer way to stop infection-caused inflammation 3Health News:Latest Cancer Clinic Closure in Selma, Alabama 2Health News:Latest Cancer Clinic Closure in Selma, Alabama 3Health News:Latest Cancer Clinic Closure in Selma, Alabama 4
(Date:7/30/2015)... N.J. , July 30, 2015  Unichem Pharmaceuticals ... recalling one lot of Hydrochlorothiazide tablets 25 mg 1000-count ... initiated as a precautionary measure due to the identification ... the product. The risk associated with ... tablet is the increased probability of experiencing Clopidogrel,s side ...
(Date:7/30/2015)... 2015  Amgen (NASDAQ: AMGN ) today announced the ... of Warburg Pincus LLC, to the Amgen Board of Directors. ... Hassan and the deep, global experience he brings in ... A. Bradway , chairman and chief executive officer of Amgen. "Fred,s ... Amgen well." Mr. Hassan has been Partner and ...
(Date:7/30/2015)... -- Growth of the U.S. nonprescription market is primarily driven ... to the OTC market. Due to an increasingly favorable ... activity over the next five years with several all ... entering the market into existing categories. If ... those with low to moderate likelihood), the market is ...
Breaking Medicine Technology:Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 3Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3
... announces that a new market research report ... IP Overview – "Monoclonal Antibodies ... http://www.reportlinker.com/p0296354/IP-Overview-–-"Monoclonal-Antibodies-against-digestive-system-cancers"-Patent-Landscape-2010.html ... digestive system cancers, monoclonal antibody-based therapies have ...
... MORRISVILLE, N.C., Sept. 21 During the recent ... the European Association of Cardiac Thoracic Surgeons in ... Surgery from University Medical Center in Ljubljana, Slovenia ... professionals to think differently about existing atrial fibrillation ...
Cached Medicine Technology:Reportlinker Adds IP Overview - "Monoclonal Antibodies against digestive system cancers" Patent Landscape 2010 2Reportlinker Adds IP Overview - "Monoclonal Antibodies against digestive system cancers" Patent Landscape 2010 3Interdisciplinary Convergent Approach May Represent Future for Treatment of Atrial Fibrillation 2Interdisciplinary Convergent Approach May Represent Future for Treatment of Atrial Fibrillation 3
... The Research Family includes fixed-volume, adjustable-volume, ... the electronic Eppendorf Research pro Pipette. ... these compact, high-performance pipettes have earned ... suited for use with original Eppendorf ...
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
... is ideal for repeated pipetting ... volume FInnpipettes offer the same ... Finnpipette Digital pipettes: New, ... Soft-touch tip ejection, Safety label, ...
... Eppendorf Reference Series 2000 Pipette is a ... a compact and robust design, and superior ... used to operate the measuring stroke and ... Product features:Eppendorf "pipette/tip" system ensures utmost accuracy ...
Medicine Products: